- Home
- HAYW vs TMDX Comparison
HAYW vs TMDX Comparison
Compare HAYW & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HAYW | TMDX |
|---|---|---|
| Founded | 1925 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electronic Components | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.6B |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | HAYW | TMDX |
|---|---|---|
| Price | $12.04 | $72.38 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 13 |
| Target Price | $16.50 | ★ $98.73 |
| AVG Volume (30 Days) | ★ 3.4M | 679.8K |
| Earning Date | 10-28-2026 | 11-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 25.93 | ★ 382.18 |
| EPS | 0.11 | ★ 0.61 |
| Revenue | ★ $1,122,155,000.00 | $605,494,000.00 |
| Revenue This Year | $5.11 | $22.57 |
| Revenue Next Year | $5.02 | $17.85 |
| P/E Ratio | ★ $106.77 | $118.51 |
| Revenue Growth | 6.71 | ★ 37.13 |
| 52 Week Low | $11.24 | $60.11 |
| 52 Week High | $17.73 | $156.00 |
Technical Indicators
Market Signals| Indicator | HAYW | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 35.31 | 34.83 |
| Support Level | $11.24 | $66.64 |
| Resistance Level | $13.32 | $79.60 |
| Average True Range (ATR) | 0.28 | 3.68 |
| MACD | 0.05 | -0.92 |
| Stochastic Oscillator | 38.11 | 15.25 |
Price Performance
Historical ComparisonAbout HAYW Hayward Holdings Inc.
Hayward Holdings is a leading manufacturer of energy-efficient swimming pool equipment and pool automation systems. The company offers a wide range of pool equipment, including pumps, filters, heaters, LED lights, and sanitization. Headquartered in Charlotte, North Carolina, the company has around 2,000 full-time employees. Hayward generated approximately $1.1 billion in revenue in 2025.
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.